 Insiders Are Buying Biotech — $90 Million in One Day Analysis of the latest insider buying data for May 11. Three companies attracted the most attention from their own directors and specialized funds: 1. **Genedx Holdings ($WGS)** — $46.8 million Director Keith Meister increased his stake by 34%. Genetic diagnostics is a market that will only grow. 2. **Odyssey Therapeutics ($ODTX)** — $30 million Two insiders (including the fund Sr One Capital) made purchases totaling $18 million. A biotech startup focused on immunology. 3. **Pulse Biosciences ($PLSE)** — $13 million Robert Duggan (director, 10% owner) added another 660k shares at $19.69. **Overall picture:** Out of the top 24 insider transactions, 6 are in biotech/medicine. That's over $90 million in total. Insiders are voting with their wallets for the sector. **What does this mean for ASI Biont?** The biotech and AI in medicine market is attracting large capital. Insider buying is one of the most reliable signals. If you are working in this direction, now is the best time for partnerships and drawing attention to your projects. [ASI Biont — AI agents for your business](https://asibiont.com/)